Instituto de Nutrição, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil.
Instituto de Nutrição Josué de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.
Cad Saude Publica. 2023 Aug 28;39(Suppl 2):e00087222. doi: 10.1590/0102-311XEN087222. eCollection 2023.
This study compared the distribution of stunting and height-for-age (HAZ) Z-scores among age groups in data from the Brazilian National Survey on Demography and Health of Women and Children (PNDS 2006) and the Brazilian National Survey on Child Nutrition (ENANI-2019). The final sample comprised 4,408 and 14,553 children < 59 months of age in the PNDS 2006 and ENANI-2019, respectively. Children with HAZ scores < -2 according to the World Health Organization (WHO) growth standard were classified as stunted. Prevalence, 95% confidence intervals (95%CI), means, and standard deviations were estimated for Brazil and according to age. The distribution of HAZ scores at each age (in months) was estimated using the svysmooth function of the R survey package. Analyses considered the complex sampling design of the studies. Statistical differences were determined by analyzing the 95%CI of the overlap of point estimates. From 2006 to 2019, the prevalence of stunting for children < 12 months of age increased from 4.7% to 9%. As expected, the smoothed curves showed a higher mean HAZ score for children < 24 months of age in 2006 than in 2019 with no overlap of 95%CI among children aged 6-12 months. For children ≥ 24 months of age, we observed a higher mean HAZ score in 2019. Although the prevalence of stunting among children < 59 months of age was similar between 2006 and 2019, mean HAZ scores among children ≥ 24 months of age increased, whereas the mean HAZ score among children < 24 months of age decreased. Considering the deterioration in living conditions and the potential impact of the COVID-19 pandemic, we expect a greater prevalence of stunting in Brazil in the near future.
本研究比较了巴西人口与妇女儿童动态调查(PNDS 2006)和巴西儿童营养状况调查(ENANI-2019)数据中不同年龄组的发育迟缓(stunting)和年龄别身高(HAZ)Z 评分分布情况。最终样本包括 PNDS 2006 中年龄<59 个月的 4408 名儿童和 ENANI-2019 中年龄<59 个月的 14553 名儿童。根据世界卫生组织(WHO)生长标准,HAZ 评分<−2 的儿童被归类为发育迟缓。根据巴西和年龄,估计了患病率、95%置信区间(95%CI)、平均值和标准差。使用 R 调查包中的 svysmooth 函数估计了每个年龄(月)的 HAZ 评分分布。分析考虑了研究的复杂抽样设计。通过分析点估计值重叠的 95%CI 来确定统计差异。2006 年至 2019 年,<12 个月的儿童发育迟缓的患病率从 4.7%上升至 9%。正如预期的那样,平滑曲线显示,2006 年<24 个月的儿童的平均 HAZ 评分较高,而 6-12 个月的儿童的 95%CI 没有重叠。对于≥24 个月的儿童,我们观察到 2019 年的平均 HAZ 评分较高。尽管 2006 年和 2019 年<59 个月的儿童发育迟缓的患病率相似,但≥24 个月的儿童的平均 HAZ 评分增加,而<24 个月的儿童的平均 HAZ 评分降低。考虑到生活条件的恶化和 COVID-19 大流行的潜在影响,我们预计巴西在不久的将来发育迟缓的患病率将会增加。